Germany pauses anti-malaria drug study for COVID-19
Several European governments moved on Wednesday to halt the use of the anti-malaria drug to treat COVID-19 patients, and a second global trial was suspended.
The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed by a pharmacist at the Rock Canyon Pharmacy in Provo, Utah, US, May 27, 2020(photo credit: GEORGE FREY/ REUTERS)ByREUTERS
